Literature DB >> 24112375

Weight change upon once-daily initiation of insulin detemir with or without dietary intervention in overweight or obese insulin-naïve individuals with type 2 diabetes: results from the DIET trial.

K Niswender1, M Piletic, H Andersen, L Conradsen Hiort, P Hollander.   

Abstract

AIMS: Weight gain upon insulin initiation is opposite to clinical goals in diabetes management. This trial aimed to determine the impact of modest dietary intervention on weight change and examine weight change in baseline body mass index strata when initiating once-daily insulin detemir (IDet) in overweight or obese insulin-naïve individuals with type 2 diabetes (T2D).
METHODS: DIET (Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes) was a 26-week, randomized, treat-to-target, stratified, controlled, open-label, multinational trial. Subjects were randomized 1 : 1 to either the IDet group, which received basic dietary and physical exercise advice at baseline, or the Diet+IDet group, which had additional dietary consultations with a certified dietician (three face-to-face meetings, three phone contacts).
RESULTS: Mean estimated change in body weight from baseline ± standard error (SE) was -1.05 ± 0.23 kg for Diet+IDet and -0.56 ± 0.23 kg for IDet alone. Estimated mean difference was 0.49 kg (95% confidence interval: -0.15; 1.13, p = 0.132). Glycaemic control, measured by haemoglobin A1c (HbA1c) and fasting plasma glucose, improved similarly in both groups. Both groups reported variable reductions in caloric intake and overall physical activity levels. No difference in hypoglycaemia rates between groups was observed.
CONCLUSION: This study suggests that a modest dietary intervention plus basic lifestyle advice, compared with basic lifestyle advice alone, resulted in similar weight change, efficacy, safety and tolerability when initiating IDet once daily in overweight or obese insulin-naïve individuals with T2D.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  HbA1c; dietary intervention; once-daily insulin detemir; type 2 diabetes; weight

Mesh:

Substances:

Year:  2013        PMID: 24112375     DOI: 10.1111/dom.12218

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  5 in total

1.  The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease.

Authors:  Octavian Savu; Viviana Elian; Oana Steriade; Ileana Teodoru; Stela Mihut; Catalin Tacu; Adrian Covic; Cristian Serafinceanu
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

2.  Effect of combined application insulin and insulin detemir on continous glucose monitor in children with type 1 diabetes mellitus.

Authors:  Xiao-Yun Chen; Qing Dong; Gui-Mei Li
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registry.

Authors:  Peter Bramlage; Tobias Bluhmki; Holger Fleischmann; Matthias Kaltheuner; Jan Beyersmann; Reinhard W Holl; Thomas Danne
Journal:  BMJ Open Diabetes Res Care       Date:  2017-01-25

Review 4.  How Effective Are Dietitians in Weight Management? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Lauren T Williams; Katelyn Barnes; Lauren Ball; Lynda J Ross; Ishtar Sladdin; Lana J Mitchell
Journal:  Healthcare (Basel)       Date:  2019-02-01

5.  Exploring the Diets of Adults with Obesity and Type II Diabetes from Nine Diverse Countries: Dietary Intakes, Patterns, and Quality.

Authors:  Jade Willey; Marian Wakefield; Heidi J Silver
Journal:  Nutrients       Date:  2020-07-08       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.